Citation: Rp. Glick et T. Lichtor, Immunotherapy Task Force for Malignant Brain Tumors - April 21, 2001, Toronto, Ontario, NEURO-ONCOL, 3(4), 2001, pp. 258-264
Authors:
Rubenstein, M
Glick, R
Lichtor, T
Mirochnik, Y
Chou, P
Guinan, P
Citation: M. Rubenstein et al., Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding - Transforming growth factor-alpha and theepidermal growth factor receptor, MED ONCOL, 18(2), 2001, pp. 121-130
Citation: Nb. Chauhan et al., Distribution of intraventricularly administered antiamyloid-beta peptide (A beta) antibody in the mouse brain, J NEUROSC R, 66(2), 2001, pp. 231-235
Authors:
Piepmeier, JM
Hedley-Whyte, ET
Rock, JP
Glick, RP
Lichtor, T
Citation: Jm. Piepmeier et al., Association between intracranial plasmacytoma and multiple myeloma: Clinicopathological outcome study - Comments, NEUROSURGER, 49(5), 2001, pp. 1044-1045
Authors:
Piepmeier, JA
Raffel, C
Glick, RP
Lichtor, T
Rutka, JT
Citation: Ja. Piepmeier et al., Immunomodulation of glioma cells after gene therapy: Induction of major histocompatibility complex class I but not class II antigen in vitro - Comments, NEUROSURGER, 49(3), 2001, pp. 688-689
Citation: R. Glick et T. Lichtor, Inhibitory effects of sodium butyrate on proliferation and invasiveness ofhuman glioma cells - Comments, NEUROSURGER, 49(2), 2001, pp. 436-436
Citation: Rp. Glick et T. Lichtor, Tumor Fas (APO-1/CD95) up-regulation results in increased apoptosis and survival times for rats with intracranial malignant gliomas - Comment, NEUROSURGER, 49(1), 2001, pp. 175-176
Citation: Rp. Glick et T. Lichtor, Caspase-9 transduction overrides the resistance mechanism against p53-mediated apoptosis in U-87MG glioma cells - Comment, NEUROSURGER, 49(1), 2001, pp. 186-186
Citation: Rp. Glick et T. Lichtor, Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha v integrin antagonist - Comments, NEUROSURGER, 48(1), 2001, pp. 157-157
Authors:
Deshmukh, P
Glick, RP
Lichtor, T
Moser, R
Cohen, EP
Citation: P. Deshmukh et al., Immunogene therapy with interleukin-2-secreting fibroblasts for intracerebrally metastasizing breast cancer in mice, J NEUROSURG, 94(2), 2001, pp. 287-292
Citation: Rp. Glick et T. Lichtor, Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model - Comment, NEUROSURGER, 47(6), 2000, pp. 1398-1399
Citation: Rp. Glick et T. Lichtor, Limitations of the C6/Wistar rat intracerebral glioma model: Implications for evaluating immunotherapy - Comment, NEUROSURGER, 47(4), 2000, pp. 1000-1000
Citation: Rp. Glick et T. Lichtor, Flow cytometric characterization of tumor-associated macrophages in experimental gliomas - Comment, NEUROSURGER, 46(4), 2000, pp. 962-962
Citation: Rp. Glick et T. Lichtor, Retinoids inhibit human glioma cell proliferation and migration in primarycell cultures but not in established cell lines - Comment, NEUROSURGER, 46(2), 2000, pp. 430-430
Authors:
Alperin, NJ
Lee, SH
Loth, F
Raksin, PB
Lichtor, T
Citation: Nj. Alperin et al., MR-intracranial pressure (ICP): A method to measure intracranial elastanceand pressure noninvasively by means of MR imaging: Baboon and human study, RADIOLOGY, 217(3), 2000, pp. 877-885
Authors:
Glick, RP
Lichtor, T
de Zoeten, E
Deshmukh, P
Cohen, EP
Citation: Rp. Glick et al., Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2, NEUROSURGER, 45(4), 1999, pp. 867-874
Citation: Rp. Glick et T. Lichtor, Inhibition of phospholipase C-gamma 1 activation blocks glioma cell motility and invasion of fetal rat brain aggregates - Comment, NEUROSURGER, 44(3), 1999, pp. 577-578